Value of Biomarker Expression for Randomized Clinical Trial Design: One (More) Missed Opportunity
Francisco E Vera-Badillo1, Andrew J Robinson1, David M Berman1
1Francisco E. Vera-Badillo, MD, MSc and Andrew J. Robinson, MD, Department of Oncology, Queen's University, Kingston, Ontario, Canada; David M. Berman, MD, PhD, Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada; and Christopher M. Booth, MD, Department of Oncology, Queen's University; and Cancer Care and Epidemiology, Queen's Research Institute, Kingston, Ontario, Canada.
Abstract
No abstract available in PubMed .
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
348
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
348
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
130
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
130